Elsaid K A, Zhang L, Shaman Z, Patel C, Schmidt T A, Jay G D
Department of Pharmaceutical Sciences, MCPHS University, Boston, MA 02115, USA.
Department of Emergency Medicine, Rhode Island Hospital, Providence, RI 02903, USA.
Osteoarthritis Cartilage. 2015 Jan;23(1):114-21. doi: 10.1016/j.joca.2014.09.006. Epub 2014 Sep 16.
Study the impact of intra-articular interleukin-1 receptor antagonist (IL-1 ra) treatment on lubricin biosynthesis following anterior cruciate ligament transection (ACLT) in the rat and evaluate the effect of combined IL-1 ra and recombinant human lubricin (rhPRG4) treatments on chondrocyte apoptosis.
ACLT was performed in male Lewis rats. Treatments included IL-1 ra or vehicle (n = 36 in each group). IL-1 ra intra-articular dosing was performed on days 1, 3, 5 and 7 following ACLT using Anakinra (150 mg/ml; 40 μl). At 3 and 5 weeks, animals were sacrificed and RNA was isolated. Histological analyses included Safranin O and H&E. Lubricin synovial fluid (SF) lavage concentrations were determined at 5 weeks. ACLT animals were treated with a single injection of vehicle, IL-1 ra (75 mg/ml; 40 μl), rhPRG4 (200 μg/ml; 40 μl), or IL-1 ra + rhPRG4 (75 mg/ml + 200 μg/ml; 40 μl) (n = 6 in each group) on day 7 following ACLT and cartilage was probed for cleaved caspase-3 at 5 weeks.
IL-1 ra treatment improved lubricin expression (P < 0.001) and lubricin SF lavage concentrations in the IL-1 ra group was higher (P = 0.005) than the vehicle. IL-1 ra treatment reduced cartilage and synovial scores (P < 0.001) compared to vehicle. IL-1 ra and rhPRG4 acted synergistically to reduce caspase-3 positive chondrocytes (P < 0.001) compared to individual treatments.
IL-1 ra treatment preserved lubricin following ACLT and a combined treatment of IL-1 ra + rhPRG4 may act synergistically to reduce cartilage catabolism.
研究关节内注射白细胞介素-1受体拮抗剂(IL-1 ra)对大鼠前交叉韧带横断(ACLT)后润滑素生物合成的影响,并评估联合使用IL-1 ra和重组人润滑素(rhPRG4)对软骨细胞凋亡的作用。
对雄性Lewis大鼠进行ACLT。治疗方法包括注射IL-1 ra或赋形剂(每组n = 36)。在ACLT后的第1、3、5和7天,使用阿那白滞素(150 mg/ml;40 μl)进行关节内注射IL-1 ra。在3周和5周时,处死动物并提取RNA。组织学分析包括番红O和苏木精-伊红染色。在5周时测定润滑素滑膜液(SF)灌洗浓度。在ACLT后第7天,对ACLT动物单次注射赋形剂、IL-1 ra(75 mg/ml;40 μl)、rhPRG4(200 μg/ml;40 μl)或IL-1 ra + rhPRG4(75 mg/ml + 200 μg/ml;40 μl)(每组n = 6),并在5周时检测软骨中裂解的半胱天冬酶-3。
IL-1 ra治疗可改善润滑素表达(P < 0.001),且IL-1 ra组的润滑素SF灌洗浓度高于赋形剂组(P = 0.005)。与赋形剂相比,IL-1 ra治疗可降低软骨和滑膜评分(P < 0.001)。与单独治疗相比,IL-1 ra和rhPRG4联合使用可协同降低半胱天冬酶-3阳性软骨细胞(P < 0.001)。
IL-1 ra治疗可在ACLT后保留润滑素,联合使用IL-1 ra + rhPRG4可能具有协同作用,以减少软骨分解代谢。